Physician

Amar Gaurang Parikh, M.D.

According to 2025 Medicare claims, Amar Parikh, M.D. (NPI: 1013448125) practices medical oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 10033-7327.

Parikh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 99 traditional Medicare patients, billed 22,196 HCPCS/CPT codes, and received $265,889 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 421 prescription claims across 99 beneficiaries totaling $1,803,853 in drug costs, led by Ibrance (Palbociclib). Open Payments data shows 174 records totaling $5,211. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $15,190 to $1,803,853. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$133K$266K2023 Medicare payment: $3,573 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $265,889 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023161,543$3,573
20249922,196$265,889

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$902K$1.8M2017 Drug cost: $15,190 (USD; Tot_Drug_Cst)2018 Drug cost: $16,218 (USD; Tot_Drug_Cst)2019 Drug cost: $38,475 (USD; Tot_Drug_Cst)2020 Drug cost: $20,395 (USD; Tot_Drug_Cst)2021 Drug cost: $594 (USD; Tot_Drug_Cst)2022 Drug cost: $3,221 (USD; Tot_Drug_Cst)2023 Drug cost: $36,351 (USD; Tot_Drug_Cst)2024 Drug cost: $1,803,853 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171485$15,190
201833219$16,218
201953291$38,475
202036180$20,395
2021N/R25$594
2022N/R16$3,221
20231428$36,351
202499421$1,803,853

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1717$157
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3563$140
96413Administration of chemotherapy into vein, 1 hour or less1755$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2537$103
99442Telephone medical discussion with physician, 11-20 minutes1417$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib22616$336,092
KisqaliRibociclib Succinate14392$237,726
XtandiEnzalutamide15450$172,539
Abiraterone AcetateAbiraterone Acetate20600$87,342
EliquisApixaban341,080$20,408

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.174$5,211Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amar Gaurang Parikh, M.D.?

Tedicare shows public-source Medicare data for Amar Gaurang Parikh, M.D. (NPI 1013448125), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amar Gaurang Parikh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amar Gaurang Parikh, M.D.?

Amar Gaurang Parikh, M.D. is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Amar Gaurang Parikh, M.D. have Open Payments data?

Amar Gaurang Parikh, M.D. has 174 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.